Clinical Trials Browser

OTHER × Neoplasms, Plasma Cell × Olanzapine × Clear all

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell